foster and thrive miconazole Miconazole nitrate 2 g/100g Cream
by Strategic Sourcing Services LLC · 1 TUBE, WITH APPLICATOR in 1 CARTON (70677-1222-1) / 45 g in 1 TUBE, WITH APPLICATOR
NDC 70677-1222-01
🏷️ FDA NDC (as labeled)
70677-1222-1
billing pads the package segment with a zero
OTC
Generic
On market
Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
⚠️
Other active recalls for Miconazole Nitrate (different manufacturers) — 1 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Jan 10, 2024 — Labeling: Not Elsewhere Classified; Product labeling contains the claim of 'Paraben Free' while the product does in fact contain parabens as part of the formulation/ ingredient list. (MEDLINE INDUSTRIES, LP - Northfield) · FDA recall D-0315-2024
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗
🆔 Identity & classification
FDA NDC (as labeled)
70677-1222-1
Product NDC
70677-1222
11-digit billing NDC
70677122201
NCPDP billing unit
GM — per gram (weight)
RxCUI
998540
UNII
VW4H1CYW1K
Application #
ANDA074760
SPL Set ID
09c4f6c9-ba51-47f4-95b4-d236fa45778b
Established class (EPC)
Azole Antifungal
Chemical class
Azoles
DEA schedule
Non-controlled
Marketing category
ANDA
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2023-10-25
Route
VAGINAL
Dosage form
CREAM
Substance
MICONAZOLE NITRATE
GPI-14
55104050103710
GCN Seq No
007003
GCN
28380
HICL code
003031
Ingredient (HICL)
Miconazole Nitrate
HIC1 code
Q
Therapeutic class — broad (HIC1)
Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code
Q4
Therapeutic class — intermediate (HIC2)
Vaginal Preparations
HIC3 code
Q4F
Therapeutic class — specific (HIC3)
Vaginal Antifungals
AHFS code
84:04.08.08
AHFS class
Azoles (Skin And Mucous Membrane)
FDB label name
FT MICONAZOLE 7 CREAM
FDB brand name
Miconazole 7
Legend status
O — Over-the-counter (OTC) drug or device
Why two NDCs?
The FDA registers this code as 70677-1222-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 70677-1222-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
🏷️ RxNorm drug class
This medicine belongs to the Azole Antifungal class.
Pharmacologic class
Azole Antifungal
Drug family (ATC)
Antiinfectives and antiseptics for local oral treatment, Imidazole derivatives, Imidazole and triazole derivatives
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.
🏭 Manufacturer & labeler
LabelerStrategic Sourcing Services LLC
Application holderL PERRIGO CO
FDA applicationANDA074760 (ANDA)
Labeler code70677
First marketedOct 2023
Product typeHuman Otc Drug
Portfolio316 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
🩺 Clinical
Label name FT MICONAZOLE 7 CREAM Ingredient Miconazole Nitrate
📗 Our plain-language guide HelloPharmacist
- For a 7-night vaginal cream, you insert one full applicator into your vagina at bedtime for 7 nights in a row. If you have itching or irritation on the outside, squeeze a small amo...
- I bought a miconazole cream for a vaginal yeast infection — how do I use it correctly?
- Yes — topical miconazole creams and powders are specifically made for those conditions. For athlete's foot and ringworm, you'd apply it to clean, dry skin twice a day for 4 weeks....
- Can I use miconazole cream on my skin for athlete's foot or jock itch?
Patient education
Supplement & herbal interactions
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
💬 Questions about Miconazole nitrate?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
🧪 Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
💲 Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per g | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | $0.119 | $5.35 / 45 g |
| Medicaid paysCMS SDUD · 12 mo | $0.2647 | $11.91 / 45 g |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
NADAC price history (per g) — tap or hover for the price & month
▼ Down 4% over the last 10 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
🔁 Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Good Sense Miconazole 7 2 g/100g 00113-0214-29 | L | 1 tube | $0.119 | — | Availability likely | — |
| good sense miconazole 7 2 g/100g 00113-0825-29 | L. | 1 tube | $0.119 | — | Availability likely | — |
| Miconazole 7 20 mg/g 00904-7734-45 | Major | 1 tube | $0.119 | — | Availability likely | — |
| Good Neighbor Pharmacy Miconazole 7 2 g/100g 24385-0590-29 | Amerisource | 1 tube | $0.119 | — | Availability likely | — |
| Miconazole Nitrate 20 mg/g 51672-2035-06 | Sun | 1 tube | $0.119 | — | Availability likely | — |
| Miconazole 7 20 mg/g 61269-0730-41 | H2-Pharma, | 1 tube | $0.119 | — | Availability likely | — |
| Miconazole 7 20 mg/g 70000-0009-01 | Cardinal | 1 tube | $0.119 | — | Availability likely | — |
| foster and thrive miconazole 2 g/100gthis 70677-1222-01 | Strategic | 1 tube | $0.119 | — | Availability likely | — |
| foster and thrive miconazole 7 2 g/100g 70677-1225-01 | Strategic | 1 tube | $0.119 | — | Availability likely | — |
| Miconazole 7 20 mg/g 83324-0160-15 | QUALITY | 1 tube | $0.119 | — | Availability likely | — |
| Miconazole 7 20 mg/g 63868-0198-45 | QUALITY | 1 tube | $0.130 | — | FDA listed | +10% |
| Miconazole 7 20 mg/g 00363-0730-41 | Walgreens | 1 tube | — | — | FDA listed | — |
| vagisil brand vagistat 2 g/100g 11509-0825-01 | Combe | 1 tube | — | — | FDA listed | — |
| Miconazole 7 20 mg/g 11673-0049-06 | TARGET | 1 tube | — | — | FDA listed | — |
| up and up miconazole 7 2 g/100g 11673-0825-29 | Target | 1 tube | — | — | FDA listed | — |
| Miconazole 7 2 g/100g 21130-0696-29 | Safeway | 1 tube | — | — | FDA listed | — |
| signature care miconazole 7 2 g/100g 21130-0825-29 | Safeway | 1 tube | — | — | FDA listed | — |
| Miconazole 7 2 g/100g 30142-0825-29 | Kroger | 1 tube | — | — | FDA listed | — |
| Topcare Miconazole 7 2 g/100g 36800-0825-29 | Topco | 1 tube | — | — | FDA listed | — |
| miconazole 7 2 g/100g 37808-0825-29 | H | 1 tube | — | — | FDA listed | — |
| Equaline Miconazole 7 2 g/100g 41163-0825-29 | United | 1 tube | — | — | FDA listed | — |
| Miconazole 7 2 g/100g 41250-0825-29 | Meijer | 1 tube | — | — | FDA listed | — |
| Careone miconazole 7 2 g/100g 41520-0825-29 | American | 1 tube | — | — | FDA listed | — |
| miconazole 7 2 g/100g 42507-0769-29 | HyVee | 1 tube | — | — | FDA listed | — |
| Miconazole 7 100 mg/g 49035-0347-07 | EQUATE | 7 tubes | — | — | FDA listed | — |
| Miconazole Nitrate 20 mg/g 50090-4356-00 | A-S | 1 tube | — | — | FDA listed | — |
| Miconazole 7 20 mg/g 55319-0573-15 | Family | 1 tube | — | — | FDA listed | — |
| DG Health Miconazole 2 g/100g 55910-0698-29 | Dolgencorp | 1 tube | — | — | FDA listed | — |
| Miconazole 7 20 mg/g 59726-0988-01 | P | 1 tube | — | — | FDA listed | — |
| Monistat 7 with Reusable Applicator 20 mg/g 63736-0025-15 | Insight | 1 tube | — | — | FDA listed | — |
| Monistat 7 7-Day Disposable Applicators 20 mg/g 63736-0026-15 | Insight | 7 tubes | — | — | FDA listed | — |
| Miconazole 7 20 mg/g 68071-3544-07 | NuCare | 1 tube | — | — | FDA listed | — |
| good sense miconazole 7 2 g/100g 68788-4117-04 | Preferred | 1 tube | — | — | FDA listed | — |
| Miconazole 7 20 mg/g 68788-7917-04 | Preferred | 1 tube | — | — | FDA listed | — |
| Miconazole 7 20 mg/g 68788-8661-04 | Preferred | 1 tube | — | — | FDA listed | — |
| Vagisten-V 7 Day 2 g/100g 69729-0612-05 | OPMX | 1 tube | — | — | FDA listed | — |
| Basic Care Miconazole 7 2 g/100g 72288-0825-29 | Amazon.com | 1 tube | — | — | FDA listed | — |
| Dr. Rainer s Vaginal Cream 2 g/100mL 73736-0115-05 | Plexoris | 1 tube | — | — | FDA listed | — |
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
⏳ Availability & generic status
🏛️
2023
On the market since
Oct 2023
📍
2026
Currently FDA-listed
3 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug
This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
🗺️ Medicaid utilization & spend
📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for 70677-1222-01, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
1.8K
Units reimbursed last 4 qtrs
81.1K
Gross reimbursed last 4 qtrs
$21.5K
Avg / prescription
$11.82
Avg / unit
$0.2647
Latest quarter Q1 2026
436Rx
Medicaid pays / g
$0.2647
gross reimbursed
vs
NADAC / g
$0.1188
acquisition cost
=
Spread
+$0.1459
+123% vs cost
What Medicaid paid per g (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
Fee-for-service · 1,136 Rx Managed care · 680 Rx
State Medicaid map
Units reimbursed · per 100k residents
1.6123
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
Prescriptions—
Units—
Reimbursed—
🏆 Top states by units · per 100k residents
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.
📊 Medicare Part D spend CMS · PART D · 2026 (Q1)
Medicare Part D (outpatient prescription) spending for Miconazole 3 (matched by generic name) — the program that covers self-administered drugs. 1 manufacturer.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Miconazole 3. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$35.6K
Claims incl. refills
725
Beneficiaries
649
Spend / beneficiary
$54.91
Spend / claim
$49.15
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.
🔬 Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for foster and thrive miconazole (this brand).
Top reported reactions
Age at onset
Reporter sex
Male · 24%
Female · 76%
Unknown · 0%
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
📦 Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Status |
|---|---|---|---|
| 70677-1222-01 You're viewing this | 1 TUBE, WITH APPLICATOR in 1 CARTON (70677-1222-1) / 45 g in 1 TUBE, WITH APPLICATOR | 2023-10-25 | Active |
📄 FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
📦 Storage and Handling
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
🎯 Indications and Usage ▾
Uses • treats vaginal yeast infections • relieves external itching and irritation due to a vaginal yeast infection
⏱️ Dosage and Administration ▾
Directions • before using this product read the enclosed consumer information leaflet for complete directions and information • adults and children 12 years of age and over: • applicator: insert 1 applicatorful into the vagina at bedtime for 7 nights in a row. Wash applicator after use. • use the same tube of cream if you have itching and irritation on the skin outside the vagina. Squeeze a small amount of cream onto your fingertip.
Apply the cream onto the itchy, irritated skin outside the vagina. Use 2 times daily for up to 7 days as needed. • children under 12 years of age: ask a doctor
⚠️ Warnings ▾
Warnings For vaginal use only Do not use if you have never had a vaginal yeast infection diagnosed by a doctor Ask a doctor before use if you have • vaginal itching and discomfort for the first time • lower abdominal, back or shoulder pain, fever, chills, nausea, vomiting, or foul-smelling vaginal discharge. You may have a more serious condition. • vaginal yeast infections often (such as once a month or 3 in 6 months). You could be pregnant or have a serious underlying medical cause for your symptoms, including diabetes or a weakened immune system. • been exposed to the human immunodeficiency virus (HIV) that causes AIDS Ask a doctor or pharmacist before use if you are taking the prescription blood thinning medicine warfarin, because bleeding or bruising may occur.
When using this product • do not use tampons, douches, spermicides or other vaginal products. Condoms and diaphragms may be damaged and fail to prevent pregnancy or sexually transmitted diseases (STDs). • do not have vaginal intercourse • mild increase in vaginal burning, itching or irritation may occur • if you do not get complete relief ask a doctor before using another product Stop use and ask a doctor if • symptoms do not get better in 3 days • symptoms last more than 7 days • you get a rash or hives, abdominal pain, fever, chills, nausea, vomiting, or foul-smelling vaginal discharge If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away (1-800-222-1222).
📦 Storage and Handling ▾
Other information • do not use if seal over tube opening has been punctured • do not purchase if carton is open • store at 20°-25°C (68°-77°F)
🧪 Active Ingredient ▾
Active ingredient Miconazole nitrate 2%
🧪 Inactive Ingredients ▾
Inactive ingredients benzoic acid, butylated hydroxyanisole, glyceryl stearate, mineral oil, peglicol 5 oleate, pegoxol 7 stearate, purified water
🎯 Purpose ▾
Purpose Vaginal antifungal
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.